Douglas R. Vogus

1.6k total citations · 2 hit papers
17 papers, 1.4k citations indexed

About

Douglas R. Vogus is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Douglas R. Vogus has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biomaterials, 7 papers in Biomedical Engineering and 6 papers in Molecular Biology. Recurrent topics in Douglas R. Vogus's work include Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Douglas R. Vogus is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Douglas R. Vogus collaborates with scholars based in United States, Spain and United Kingdom. Douglas R. Vogus's co-authors include Samir Mitragotri, Stefano Menegatti, Aaron C. Anselmo, Sunny Kumar, Matthew E. Helgeson, Mengwen Zhang, Vinu Krishnan, Todd M. Squires, Anusha Pusuluri and Ming Chen and has published in prestigious journals such as Angewandte Chemie International Edition, ACS Nano and Journal of Colloid and Interface Science.

In The Last Decade

Douglas R. Vogus

17 papers receiving 1.4k citations

Hit Papers

Elasticity of Nanoparticles Influences Their Blood Circul... 2014 2026 2018 2022 2015 2014 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas R. Vogus United States 14 659 549 491 194 113 17 1.4k
Blaine J. Zern United States 16 580 0.9× 463 0.8× 487 1.0× 156 0.8× 130 1.2× 19 1.4k
Apoorva Sarode United States 16 355 0.5× 371 0.7× 415 0.8× 105 0.5× 91 0.8× 20 1.1k
Sharon M. Sagnella Australia 27 786 1.2× 470 0.9× 774 1.6× 216 1.1× 58 0.5× 45 1.8k
Olivier Meyer United States 10 798 1.2× 379 0.7× 882 1.8× 135 0.7× 81 0.7× 17 1.6k
Marilena Hadjidemetriou United Kingdom 16 985 1.5× 670 1.2× 837 1.7× 271 1.4× 79 0.7× 22 1.7k
Sunny Kumar India 12 478 0.7× 383 0.7× 492 1.0× 135 0.7× 159 1.4× 36 1.2k
Alexandros Marios Sofias Germany 17 447 0.7× 505 0.9× 494 1.0× 128 0.7× 164 1.5× 32 1.2k
Peter P. Wibroe Denmark 12 377 0.6× 303 0.6× 361 0.7× 145 0.7× 206 1.8× 14 996
Svenja Winzen Germany 13 1.0k 1.5× 594 1.1× 661 1.3× 328 1.7× 104 0.9× 17 1.8k
Alexander Malugin United States 16 675 1.0× 528 1.0× 464 0.9× 504 2.6× 74 0.7× 20 1.5k

Countries citing papers authored by Douglas R. Vogus

Since Specialization
Citations

This map shows the geographic impact of Douglas R. Vogus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas R. Vogus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas R. Vogus more than expected).

Fields of papers citing papers by Douglas R. Vogus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas R. Vogus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas R. Vogus. The network helps show where Douglas R. Vogus may publish in the future.

Co-authorship network of co-authors of Douglas R. Vogus

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas R. Vogus. A scholar is included among the top collaborators of Douglas R. Vogus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas R. Vogus. Douglas R. Vogus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Krishnan, Vinu, Kevin Peng, Apoorva Sarode, et al.. (2021). Hyaluronic acid conjugates for topical treatment of skin cancer lesions. Science Advances. 7(24). 27 indexed citations
2.
Wu, Debra, Douglas R. Vogus, Vinu Krishnan, et al.. (2021). Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes. Pharmaceutics. 13(1). 107–107. 4 indexed citations
3.
Gao, Yongsheng, Douglas R. Vogus, Zongmin Zhao, et al.. (2021). Injectable hyaluronic acid hydrogels encapsulating drug nanocrystals for long‐term treatment of inflammatory arthritis. Bioengineering & Translational Medicine. 7(1). e10245–e10245. 31 indexed citations
4.
Wu, Debra, Anusha Pusuluri, Douglas R. Vogus, et al.. (2020). Design principles of drug combinations for chemotherapy. Journal of Controlled Release. 323. 36–46. 42 indexed citations
5.
Gregory, Jason V., et al.. (2020). Programmable Delivery of Synergistic Cancer Drug Combinations Using Bicompartmental Nanoparticles. Advanced Healthcare Materials. 9(21). e2000564–e2000564. 17 indexed citations
6.
Vogus, Douglas R., et al.. (2019). Design strategies for engineering soluto-inertial suspension interactions. Physical review. E. 100(5). 52603–52603. 5 indexed citations
7.
Pusuluri, Anusha, Vinu Krishnan, Apoorva Sarode, et al.. (2018). Treating Tumors at Low Drug Doses Using an Aptamer–Peptide Synergistic Drug Conjugate. Angewandte Chemie. 131(5). 1451–1455. 9 indexed citations
8.
Pusuluri, Anusha, Vinu Krishnan, Apoorva Sarode, et al.. (2018). Treating Tumors at Low Drug Doses Using an Aptamer–Peptide Synergistic Drug Conjugate. Angewandte Chemie International Edition. 58(5). 1437–1441. 57 indexed citations
9.
Vogus, Douglas R., Vinu Krishnan, & Samir Mitragotri. (2017). A review on engineering polymer drug conjugates to improve combination chemotherapy. Current Opinion in Colloid & Interface Science. 31. 75–85. 56 indexed citations
10.
Vogus, Douglas R., Michael A. Evans, Anusha Pusuluri, et al.. (2017). A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer. Journal of Controlled Release. 267. 191–202. 78 indexed citations
11.
Vogus, Douglas R., Anusha Pusuluri, Renwei Chen, & Samir Mitragotri. (2017). Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro‐in vivo correlation. Bioengineering & Translational Medicine. 3(1). 49–57. 28 indexed citations
12.
Camacho, Kathryn M., Stefano Menegatti, Douglas R. Vogus, et al.. (2016). DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy. Journal of Controlled Release. 229. 154–162. 51 indexed citations
13.
Camacho, Kathryn M., Sunny Kumar, Stefano Menegatti, et al.. (2015). Synergistic antitumor activity of camptothecin–doxorubicin combinations and their conjugates with hyaluronic acid. Journal of Controlled Release. 210. 198–207. 87 indexed citations
14.
Anselmo, Aaron C., Mengwen Zhang, Sunny Kumar, et al.. (2015). Elasticity of Nanoparticles Influences Their Blood Circulation, Phagocytosis, Endocytosis, and Targeting. ACS Nano. 9(3). 3169–3177. 528 indexed citations breakdown →
15.
Vogus, Douglas R., Vincent Mansard, M. Rapp, & Todd M. Squires. (2015). Measuring concentration fields in microfluidic channels in situ with a Fabry–Perot interferometer. Lab on a Chip. 15(7). 1689–1696. 16 indexed citations
16.
Anselmo, Aaron C., Christa L. Modery-Pawlowski, Stefano Menegatti, et al.. (2014). Platelet-like Nanoparticles: Mimicking Shape, Flexibility, and Surface Biology of Platelets To Target Vascular Injuries. ACS Nano. 8(11). 11243–11253. 293 indexed citations breakdown →
17.
Alvarez, Nicolas J., Douglas R. Vogus, Lynn M. Walker, & Shelley L. Anna. (2012). Using bulk convection in a microtensiometer to approach kinetic-limited surfactant dynamics at fluid–fluid interfaces. Journal of Colloid and Interface Science. 372(1). 183–191. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026